Charles Schwab’s Streamline Health Solutions STRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,935
Closed -$13.4K 3590
2024
Q2
$13.4K Hold
1,935
﹤0.01% 3605
2024
Q1
$13.9K Hold
1,935
﹤0.01% 3452
2023
Q4
$12.3K Hold
1,935
﹤0.01% 3515
2023
Q3
$28.1K Hold
1,935
﹤0.01% 3477
2023
Q2
$36.9K Hold
1,935
﹤0.01% 3467
2023
Q1
$52.3K Hold
1,935
﹤0.01% 3340
2022
Q4
$45.9K Hold
1,935
﹤0.01% 3375
2022
Q3
$35K Buy
+1,935
New +$43.4K ﹤0.01% 3411

Other funds holding STRM

Charles Schwab's STRM Position: Q3 2024 in Review

Charles Schwab sold out of Streamline Health Solutions (STRM) in Q3 2024, closing a stake of 1,935 shares — an estimated $13.4K sold.

Charles Schwab first reported a position in STRM in Q3 2022 and held it in 8 quarters. The position peaked at $52.3K in Q1 2023. 26 funds tracked by Wall St. Rank hold STRM as of Q3 2024.

  • Charles Schwab reported no remaining Streamline Health Solutions position as of Q3 2024 after selling out during the quarter.
  • Charles Schwab sold 1,935 Streamline Health Solutions shares in Q3 2024, an estimated $13.4K.
  • Charles Schwab first reported a position in Streamline Health Solutions in Q3 2022 and held it in 8 quarters.
  • Charles Schwab's Streamline Health Solutions position peaked at $52.3K in Q1 2023.
  • 26 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q3 2024.

Based on Charles Schwab's 13F filing for Q3 2024, filed 12 Nov 2024.